This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
LHC Group Future Growth
Future criteria checks 4/6
Key information
37.2%
Earnings growth rate
35.5%
EPS growth rate
Healthcare earnings growth | 16.0% |
Revenue growth rate | 8.9% |
Future return on equity | 8.6% |
Analyst coverage | Good |
Last updated | n/a |
Recent future growth updates
Recent updates
LHC Group GAAP EPS of $0.35 misses by $0.95, revenue of $576.2M misses by $29.82M
Aug 03LHC Group: UnitedHealth Merger Is Worth Playing
Jul 19FTC second request in LHC Group/UnitedHealth said to probe pay, labor market
Jul 06These 4 Measures Indicate That LHC Group (NASDAQ:LHCG) Is Using Debt Safely
Feb 24With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Feb 06LHC Group (NASDAQ:LHCG) Has A Rock Solid Balance Sheet
Nov 25Is Now The Time To Put LHC Group (NASDAQ:LHCG) On Your Watchlist?
Nov 07Why We Think Shareholders May Be Considering Bumping Up LHC Group, Inc.'s (NASDAQ:LHCG) CEO Compensation
Jun 03LHC Group, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 10With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Mar 25Are LHC Group, Inc.'s (NASDAQ:LHCG) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 07Is LHC Group, Inc. (NASDAQ:LHCG) Trading At A 45% Discount?
Feb 17Does LHC Group (NASDAQ:LHCG) Have A Healthy Balance Sheet?
Feb 04LHC Group, Inc. (NASDAQ:LHCG) Insiders Have Been Selling
Jan 19Here's Why LHC Group's (NASDAQ:LHCG) Statutory Earnings Are Arguably Too Conservative
Jan 06Here's Why We Think LHC Group (NASDAQ:LHCG) Is Well Worth Watching
Dec 24Did You Miss LHC Group's (NASDAQ:LHCG) Whopping 338% Share Price Gain?
Dec 12LHC Group, Inc. (NASDAQ:LHCG) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 30Estimating The Fair Value Of LHC Group, Inc. (NASDAQ:LHCG)
Nov 18LHC Group, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 2,580 | 155 | N/A | N/A | 4 |
12/31/2023 | 2,446 | 146 | 182 | 182 | 8 |
12/31/2022 | 2,283 | 40 | 30 | 50 | N/A |
9/30/2022 | 2,308 | 63 | -62 | -39 | N/A |
6/30/2022 | 2,297 | 73 | -119 | -91 | N/A |
3/31/2022 | 2,266 | 101 | -245 | -210 | N/A |
12/31/2021 | 2,220 | 116 | -133 | -100 | N/A |
9/30/2021 | 2,169 | 130 | -16 | 22 | N/A |
6/30/2021 | 2,134 | 117 | 41 | 82 | N/A |
3/31/2021 | 2,075 | 124 | 541 | 599 | N/A |
12/31/2020 | 2,063 | 112 | 463 | 529 | N/A |
9/30/2020 | 2,062 | 103 | 412 | 481 | N/A |
6/30/2020 | 2,060 | 119 | 441 | 508 | N/A |
3/31/2020 | 2,091 | 99 | 30 | 75 | N/A |
12/31/2019 | 2,080 | 96 | 97 | 130 | N/A |
9/30/2019 | 2,059 | 94 | 98 | 127 | N/A |
6/30/2019 | 2,037 | 86 | 110 | 137 | N/A |
3/31/2019 | 2,021 | 77 | 73 | 106 | N/A |
12/31/2018 | 1,810 | 64 | 76 | 109 | N/A |
9/30/2018 | 1,591 | 61 | 36 | 57 | N/A |
6/30/2018 | 1,354 | 51 | 1 | 19 | N/A |
3/31/2018 | 1,109 | 46 | 21 | 32 | N/A |
12/31/2017 | 1,063 | 50 | 22 | 32 | N/A |
9/30/2017 | 1,004 | 41 | 62 | 71 | N/A |
6/30/2017 | 962 | 40 | 72 | 79 | N/A |
3/31/2017 | 926 | 38 | 69 | 85 | N/A |
12/31/2016 | 900 | 37 | 51 | 67 | N/A |
9/30/2016 | 882 | 35 | N/A | 66 | N/A |
6/30/2016 | 854 | 34 | N/A | 43 | N/A |
3/31/2016 | 827 | 33 | N/A | 54 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LHCG's forecast earnings growth (37.2% per year) is above the savings rate (2.1%).
Earnings vs Market: LHCG's earnings (37.2% per year) are forecast to grow faster than the US market (14.2% per year).
High Growth Earnings: LHCG's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LHCG's revenue (8.9% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: LHCG's revenue (8.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LHCG's Return on Equity is forecast to be low in 3 years time (8.6%).